AGC
AMGN icon

Aspen Grove Capital’s Amgen AMGN Stock Holding History

Aspen Grove Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Hold
2,888
– – 0.2% 67
2025
Q4 		$946K Buy
2,888
+8
+0.3% +$2.54K 0.16% 70
2025
Q3 		$813K Sell
2,880
-104
-3% -$30.2K 0.14% 74
2025
Q2 		$833K Buy
2,984
+265
+10% +$75.1K 0.14% 79
2025
Q1 		$847K Buy
2,719
+106
+4% +$31.3K 0.16% 78
2024
Q4 		$681K Sell
2,613
-29
-1% -$8.6K 0.14% 85
2024
Q3 		$851K Hold
2,642
– – 0.19% 74
2024
Q2 		$825K Buy
2,642
+16
+0.6% +$4.7K 0.19% 71
2024
Q1 		$747K Buy
2,626
+11
+0.4% +$3.22K 0.21% 72
2023
Q4 		$750K Buy
2,615
+87
+3% +$23.7K 0.23% 73
2023
Q3 		$679K Buy
2,528
+93
+4% +$23.2K 0.25% 71
2023
Q2 		$541K Sell
2,435
-136
-5% -$31.6K 0.17% 107
2023
Q1 		$622K Buy
2,571
+57
+2% +$14K 0.27% 74
2022
Q4 		$660K Buy
+2,514
New +$674K 0.31% 67

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aspen Grove Capital's AMGN Position: Q1 2026 in Review

Aspen Grove Capital held its Amgen (AMGN) position steady in Q1 2026 at 2,888 shares worth $1.02M. The position accounts for 0.2% of the portfolio, ranked #67.

Aspen Grove Capital first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aspen Grove Capital held 2,888 shares of Amgen worth $1.02M as of Q1 2026.
  • Aspen Grove Capital left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.2% of Aspen Grove Capital's portfolio in Q1 2026, its #67 holding.
  • Aspen Grove Capital first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aspen Grove Capital's 13F filing for Q1 2026, filed 14 May 2026.